For information only - not an official document
3 September 2020
The International Narcotics Control Board holds postponed 128th session, renews President's mandate and elects new Bureau Members
VIENNA, 3 September (United Nations Information Service) - How to ensure the availability of internationally controlled substances for medical and scientific purposes while preventing illicit cultivation and production, diversion, trafficking and abuse, including during the COVID-19 pandemic is being discussed this week in Vienna at the International Narcotics Control Board (INCB) 128th session. Postponed from May 2020 due to the COVID-19 pandemic, it is being held in a hybrid format to enable Members to participate virtually from around the world. At elections held yesterday, the Board renewed the mandate of its President, Cornelis P. de Joncheere, and elected a new Bureau for a one-year term.
During the session, which is taking place from 31 August to 4 September 2020, the Board is reviewing the compliance of Member States with the three international drug control conventions and the functioning of the international drug control system.
The session opened with a meeting of the Board's Standing Committee on Estimates, which looked at national estimates of requirements for narcotic drugs and psychotropic substances for medical and scientific purposes and reviewed annual legitimate requirements of precursors for licit industrial use submitted by governments for those chemicals that are frequently subject to diversion to the illicit manufacture of drugs.
In plenary, the Board is working on the preparation of its annual report for 2020, which will include a thematic chapter on drug use among older persons and is considering civil society perspectives on the topic in the form of written submissions provided by the Vienna Non-Governmental Organizations (NGO) Committee on Drugs. During the session, the Board will meet with the Executive Director of the United Nations Office on Drugs and Crime (UNODC), Ghada Waly.
At the opening of the session, the Board welcomed three new Members, who had been elected by the Economic and Social Council in 2019: César T. Arce Rivas, Viviana Manrique Zuluaga and Zukiswa Zingela.
The composition of the INCB Bureau following the 2 September elections:
- Cornelis P. de Joncheere - President of the Board
- Luis A. Otárola Peñaranda - First Vice-President
- Jagjit Pavadia - Second Vice-President and Chair of the Standing Committee on Estimates, and Member, Committee on Finance and Administration
- Bernard Leroy - Rapporteur
Officers elected by the Board:
- Raúl Martín del Campo Sánchez - Vice-Chair of the Standing Committee on Estimates
- H. H. Sevil Atasoy - Chair of the Committee on Finance and Administration, and Member, Standing Committee on Estimates
- César T. Arce Rivas - Member, Standing Committee on Estimates
- David T. Johnson - Member, Standing Committee on Estimates, and Member, Committee on Finance and Administration
- Viviana Manrique Zuluaga - Member, Standing Committee on Estimates
- Zukiswa Zingela - Member, Standing Committee on Estimates
- Galina A. Korchagina - Member, Committee on Finance and Administration
INCB is the independent, quasi-judicial body charged with promoting and monitoring Government compliance with the three international drug control conventions: the 1961 Single Convention on Narcotic Drugs, the 1971 Convention on Psychotropic Substances, and the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. Established by the Single Convention on Narcotic Drugs of 1961, the thirteen members of the Board are elected in a personal capacity by the Economic and Social Council for terms of five years.
* *** *
For further information please contact:
Telephone for media inquiries: (+43-1) 26060 4163